Corient Private Wealth
CDLX icon

Corient Private Wealth’s Cardlytics CDLX Stock Holding History

Corient Private Wealth’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,000
Closed -$21K – 3072
2026
Q1 		$21K Buy
2,000
+1,000
+100% +$9.76K ﹤0.01% 2781
2025
Q4 		$11.5K Hold
1,000
– – ﹤0.01% 2632
2025
Q3 		$24.3K Hold
1,000
– – ﹤0.01% 2525
2025
Q2 		$16.4K Buy
+1,000
New +$17.3K ﹤0.01% 2414

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Corient Private Wealth's CDLX Position: Q2 2026 in Review

Corient Private Wealth sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 2,000 shares — an estimated $21K sold.

Corient Private Wealth first reported a position in CDLX in Q2 2025 and held it in 4 quarters. The position peaked at $24.3K in Q3 2025. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Corient Private Wealth reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
  • Corient Private Wealth sold 2,000 Cardlytics shares in Q2 2026, an estimated $21K.
  • Corient Private Wealth first reported a position in Cardlytics in Q2 2025 and held it in 4 quarters.
  • Corient Private Wealth's Cardlytics position peaked at $24.3K in Q3 2025.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.